Globus Medical, Inc. (GMED) DCF Valuation
- ✓ Entièrement Modifiable: Adapté À Vos Besoins Dans Excel Ou Sheets
- ✓ Conception Professionnelle: Modèles Fiables Et Conformes Aux Normes Du Secteur
- ✓ Pré-Construits Pour Une Utilisation Rapide Et Efficace
- ✓ Aucune Expertise N'Est Requise; Facile À Suivre
Globus Medical, Inc. (GMED) Bundle
Simplify Globus Medical, Inc. (GMED) valuation with this customizable DCF Calculator! Featuring real Globus Medical, Inc. (GMED) financials and adjustable forecast inputs, you can test scenarios and uncover Globus Medical, Inc. (GMED) fair value in minutes.
Discounted Cash Flow (DCF) - (USD MM)
Year | AY1 2019 |
AY2 2020 |
AY3 2021 |
AY4 2022 |
AY5 2023 |
FY1 2024 |
FY2 2025 |
FY3 2026 |
FY4 2027 |
FY5 2028 |
---|---|---|---|---|---|---|---|---|---|---|
Revenue | 785.4 | 789.0 | 958.1 | 1,022.8 | 1,568.5 | 1,890.0 | 2,277.4 | 2,744.3 | 3,306.8 | 3,984.7 |
Revenue Growth, % | 0 | 0.46781 | 21.43 | 6.76 | 53.34 | 20.5 | 20.5 | 20.5 | 20.5 | 20.5 |
EBITDA | 242.7 | 178.3 | 250.3 | 304.5 | 310.1 | 488.3 | 588.3 | 708.9 | 854.3 | 1,029.4 |
EBITDA, % | 30.9 | 22.6 | 26.12 | 29.77 | 19.77 | 25.83 | 25.83 | 25.83 | 25.83 | 25.83 |
Depreciation | 52.7 | 62.9 | 69.9 | 68.3 | 144.7 | 143.2 | 172.5 | 207.9 | 250.5 | 301.8 |
Depreciation, % | 6.71 | 7.97 | 7.29 | 6.67 | 9.23 | 7.58 | 7.58 | 7.58 | 7.58 | 7.58 |
EBIT | 189.9 | 115.5 | 180.4 | 236.3 | 165.4 | 345.1 | 415.8 | 501.1 | 603.8 | 727.5 |
EBIT, % | 24.19 | 14.63 | 18.83 | 23.1 | 10.54 | 18.26 | 18.26 | 18.26 | 18.26 | 18.26 |
Total Cash | 311.5 | 426.7 | 443.4 | 446.1 | 517.8 | 818.9 | 986.8 | 1,189.1 | 1,432.8 | 1,726.6 |
Total Cash, percent | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 |
Account Receivables | 162.4 | 148.1 | 165.7 | 217.3 | 504.9 | 416.5 | 501.8 | 604.7 | 728.7 | 878.0 |
Account Receivables, % | 20.68 | 18.77 | 17.29 | 21.25 | 32.19 | 22.03 | 22.03 | 22.03 | 22.03 | 22.03 |
Inventories | 196.3 | 229.2 | 237.0 | 299.0 | 848.1 | 612.7 | 738.2 | 889.6 | 1,071.9 | 1,291.7 |
Inventories, % | 25 | 29.04 | 24.74 | 29.23 | 54.07 | 32.42 | 32.42 | 32.42 | 32.42 | 32.42 |
Accounts Payable | 24.6 | 18.2 | 22.0 | 36.1 | 56.7 | 56.2 | 67.8 | 81.6 | 98.4 | 118.5 |
Accounts Payable, % | 3.13 | 2.31 | 2.29 | 3.53 | 3.61 | 2.98 | 2.98 | 2.98 | 2.98 | 2.98 |
Capital Expenditure | -70.8 | -63.7 | -56.9 | -74.0 | -78.3 | -133.2 | -160.5 | -193.4 | -233.1 | -280.9 |
Capital Expenditure, % | -9.01 | -8.07 | -5.94 | -7.24 | -4.99 | -7.05 | -7.05 | -7.05 | -7.05 | -7.05 |
Tax Rate, % | 25.71 | 25.71 | 25.71 | 25.71 | 25.71 | 25.71 | 25.71 | 25.71 | 25.71 | 25.71 |
EBITAT | 155.2 | 93.8 | 149.2 | 184.9 | 122.9 | 274.8 | 331.2 | 399.0 | 480.8 | 579.4 |
Depreciation | ||||||||||
Changes in Account Receivables | ||||||||||
Changes in Inventories | ||||||||||
Changes in Accounts Payable | ||||||||||
Capital Expenditure | ||||||||||
UFCF | -196.9 | 68.1 | 140.5 | 79.6 | -626.8 | 608.2 | 143.7 | 173.2 | 208.7 | 251.4 |
WACC, % | 9.64 | 9.64 | 9.64 | 9.63 | 9.62 | 9.64 | 9.64 | 9.64 | 9.64 | 9.64 |
PV UFCF | ||||||||||
SUM PV UFCF | 1,108.9 | |||||||||
Long Term Growth Rate, % | 4.00 | |||||||||
Free cash flow (T + 1) | 261 | |||||||||
Terminal Value | 4,639 | |||||||||
Present Terminal Value | 2,929 | |||||||||
Enterprise Value | 4,038 | |||||||||
Net Debt | 53 | |||||||||
Equity Value | 3,984 | |||||||||
Diluted Shares Outstanding, MM | 115 | |||||||||
Equity Value Per Share | 34.76 |
What You Will Get
- Real GMED Financials: Access to historical and projected data for precise valuation.
- Customizable Inputs: Adjust WACC, tax rates, revenue growth, and capital expenditures as needed.
- Dynamic Calculations: Intrinsic value and NPV are computed in real-time.
- Scenario Analysis: Explore various scenarios to assess Globus Medical's future performance.
- User-Friendly Design: Tailored for professionals while remaining approachable for newcomers.
Key Features
- Customizable Forecast Inputs: Adjust vital metrics such as revenue growth, EBITDA %, and capital expenditures.
- Instant DCF Valuation: Quickly computes intrinsic value, NPV, and additional outputs.
- High-Precision Accuracy: Leverages Globus Medical's actual financial data for credible valuation results.
- Effortless Scenario Analysis: Evaluate various assumptions and compare results with ease.
- Efficiency Booster: Remove the necessity of constructing intricate valuation models from the ground up.
How It Works
- Step 1: Download the Excel file for Globus Medical, Inc. (GMED).
- Step 2: Review the pre-filled financial data and forecasts for Globus Medical.
- Step 3: Adjust key inputs such as revenue growth, WACC, and tax rates (highlighted cells).
- Step 4: Observe the DCF model update in real-time as you modify your assumptions.
- Step 5: Evaluate the outputs and leverage the results for your investment strategies.
Why Choose This Calculator for Globus Medical, Inc. (GMED)?
- Accurate Data: Up-to-date Globus Medical financials provide trustworthy valuation outcomes.
- Customizable: Tailor essential inputs like growth rates, WACC, and tax rates to fit your forecasts.
- Time-Saving: Ready-made calculations save you from having to build from the ground up.
- Professional-Grade Tool: Crafted for investors, analysts, and consultants in the medical device sector.
- User-Friendly: Simple design and clear instructions ensure accessibility for all users.
Who Should Use This Product?
- Professional Investors: Develop comprehensive and accurate valuation models for investment analysis in Globus Medical, Inc. (GMED).
- Corporate Finance Teams: Evaluate valuation scenarios to inform strategic decisions within the organization.
- Consultants and Advisors: Deliver precise valuation insights to clients regarding Globus Medical, Inc. (GMED).
- Students and Educators: Utilize real-world data to enhance learning and practice in financial modeling.
- Healthcare Industry Analysts: Gain insights into how medical device companies like Globus Medical, Inc. (GMED) are valued in the market.
What the Template Contains
- Pre-Filled Data: Contains Globus Medical’s historical financials and projections.
- Discounted Cash Flow Model: An editable DCF valuation model with automated calculations.
- Weighted Average Cost of Capital (WACC): A dedicated sheet for calculating WACC based on user-defined inputs.
- Key Financial Ratios: Evaluate Globus Medical’s profitability, efficiency, and leverage metrics.
- Customizable Inputs: Easily adjust revenue growth, profit margins, and tax rates.
- Clear Dashboard: Visual representations and tables summarizing essential valuation outcomes.